NCT02961504 - Treatment Evaluation of Acute Stroke for Using in Regenerative Cell Elements | Biotech Hunter

Enrollment

206

Participants

Timeline

Start Date

November 15, 2017

Primary Completion Date

March 31, 2021

Study Completion Date

February 28, 2023

Conditions

Stroke, Acute

Interventions

BIOLOGICAL

HLCM051

Within 18 to 36 hours after the onset of ischemic stroke, subjects will receive a single dose of 1.2 billion HLCM051 cells to be intravenously administered

BIOLOGICAL

Placebo

Within 18 to 36 hours after the onset of ischemic stroke, subjects will receive a single dose of placebo to be intravenously administered

Trial Locations (1)

060-8648

Hokkaido University Hospital, Sapporo